Stay updated on CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial
Sign up to get notified when there's something new on the CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial page.

Latest updates to the CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedNow the page displays a 403 Forbidden error, blocking access to the study record instead of showing the study details. This indicates an access-control issue rather than an update to the study information.SummaryDifference17%

- Check41 days agoChange DetectedThe page updates its version label from v3.6.5 to v3.6.6, representing a small site update without changes to the study information.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing the previous v3.6.4. This appears to be a small site update rather than a change to the study information.SummaryDifference0.1%

- Check76 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4, signaling a newer build of the site. This likely reflects internal updates or fixes that do not alter the displayed study information.SummaryDifference0.1%

- Check98 days agoChange DetectedThe page revision tag was updated from v3.6.2 to v3.6.3, indicating a minor update to the page metadata or content.SummaryDifference0.1%

- Check105 days agoChange DetectedAdded the page revision tag Revision: v3.6.2 and removed Revision: v3.6.0, reflecting an update to the page's revision history.SummaryDifference0.1%

Stay in the know with updates to CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTX130 in Relapsed/Refractory T/B Malignancies Clinical Trial page.